Gastric Ischemic Preconditioning Before Esophagectomy

June 6, 2024 updated by: LIVIN Marie, CHU Rennes - Hopital Pontchaillou

Short-term Outcomes of Gastric Ischemic Preconditioning Before Esophagectomy With Preoperative Embolization of the Left Gastric Artery: A Prospective Single-Center Study

The aim of the study is to investigate the impact of left gastric artery embolization before esophagectomy on postoperative complications, particularly anastomotic leaks and necrosis of the gastric conduit.

Study Overview

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bretagne
      • Rennes, Bretagne, France, 35000
        • Livin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery.

Description

Inclusion Criteria:

Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery.

Exclusion Criteria:

Patient with no operable esophageal cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient who underwent Gastric Ischemic Preconditioning Before Esophagectomy
Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery
Does embolization of the left gastric artery prior oesophagectomy reduce postoperative complications, particularly anastomotic leaks and ischemia of the gastric conduit?

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Anastomotic leak
Time Frame: 6 months
6 months
Anastomotic stenosis
Time Frame: 6 months
6 months
Gastric conduit necrosis
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

June 2, 2024

First Submitted That Met QC Criteria

June 6, 2024

First Posted (Actual)

June 11, 2024

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 6, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CHU Pontchaillou Rennes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Operable Esophageal Cancer

Clinical Trials on Gastric Ischemic Preconditioning Before Esophagectomy

Subscribe